Healthcare ETFs Are Latest Victim to Trump
Healthcare stocks, especially the biotech segment, and related exchange traded funds plunged Wednesday after President-elect Donald Trump singled out the rising drug prices at a press conference. The healthcare sector was the worst performing area of the equities market on Wednesday, with the Health Care Select Sector SPDR (NYSEArca: XLV) down 1.3%. Meanwhile, biotech-related ETFs… Click to read more at ETFtrends.com.
This article was provided by our partner Tom Lydon of etftrends.com.